Cal Robinson
banner
kidneycal.bsky.social
Cal Robinson
@kidneycal.bsky.social
SickKids Pediatric Nephrology | PhD student | Toronto 🇨🇦 | Aspiring clinician-scientist | Adaptive clinical trials, target trial emulation, and health admin data research

https://www.researchgate.net/profile/Cal-Robinson-2
Yet calcineurin inhibitor treatment was associated with more hospitalizations and IV albumin use, likely related to its nephrotoxic effects. Medication costs, local access, treatment duration, and side effect profiles should be considered when deciding between steroid-sparing meds in childhood NS
January 27, 2025 at 10:10 PM